1415502-42-9

Basic information

• Product Name: methyl (3S)-3-{[(1S)-1-(4-methoxyphenyl)ethyl]amino}indane-1-carboxylate
• Synonyms: methyl (3S)-3-{[(1S)-1-(4-methoxyphenyl)ethyl]amino}indane-1-carboxylate
• CAS NO: 1415502-42-9
• Molecular Weight: 325.408
• Mol File: 1415502-42-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: methyl (3S)-3-{[(1S)-1-(4-methoxyphenyl)ethyl]amino}indane-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl (3S)-3-{[(1S)-1-(4-methoxyphenyl)ethyl]amino}indane-1-carboxylate(1415502-42-9)
• EPA Substance Registry System: methyl (3S)-3-{[(1S)-1-(4-methoxyphenyl)ethyl]amino}indane-1-carboxylate(1415502-42-9)

Safety Data

• Hazardous Substances Data: 1415502-42-9(Hazardous Substances Data)

Upstream product

• 29427-70-1 methyl 3-oxo-2,3-dihydro-1H-indene-1-carboxylate 
• 6298-96-0 (S)-1-(4-methoxyphenyl)ethylamine 

Relevant articles and documents

IMIDAZOPYRIDINE COMPOUNDS

[Problem] An excellent drug for treating or preventing cardiovascular diseases, based on cGMP production enhancing action due to soluble guanylate cyclase activating action, is provided. [Means for Solution] It was found that imidazopyridine compounds having a carbamoyl group at the 3-position and a substituent bonded at the 8-position via an oxygen atom in an imidazo[1,2-a]pyridine skeleton exhibits a cGMP production enhancing action by a potent soluble guanylate cyclase activating action, and is useful as a drug for treating or preventing various soluble guanylate cyclase-related cardiovascular diseases, thereby completing the present invention.